Insider trades
Eric Karas, Chief Officer of ARS Pharmaceuticals SPRY, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $250K. The latest trade was on 06/12.
Eric Karas
Chief Commercial Officer
- Company
- ARS Pharmaceuticals SPRY
- First filing
- 23/01/05
- Trades
- 28 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$250K
- Last trade
- 06/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/12 | 06/12 | 25,000 sh | $10.00 | $250,000 | −67.2% | |
| Open-market sale10b5-1 plan | 25/07/01 | 25/07/03 | 15,000 sh | $16.99 | $254,850 | −59.3% | |
| Open-market sale10b5-1 plan | 25/06/18 | 25/06/20 | 15,000 sh | $16.00 | $240,000 | −66.1% | |
| Open-market sale10b5-1 plan | 25/03/20 | 25/03/21 | 10,000 sh | $14.00 | $140,000 | −56.5% | |
SPRY | Open-market sale10b5-1 plan | 24/12/02–24/12/04 | 24/12/04 | 10,000 sh2 trades | $14.04avg. | $140,408.87 | −63.7% |
| Open-market sale10b5-1 plan | 24/09/18 | 24/09/19 | 10,000 sh | $14.00 | $140,000 | −63.7% | |
| Open-market sale10b5-1 plan | 24/08/19 | 24/08/21 | 10,000 sh | $14.00 | $140,000 | −63.7% |